Selection bias due to delayed comprehensive genomic profiling in Japan-Reference-Cited by-同舟云学术

Selection bias due to delayed comprehensive genomic profiling in Japan

Published:2022-11-27 Issue:3 Volume:114 Page:1015-1025
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Tamura Taichi¹,Ikegami Masachika²^ORCID,Kanemasa Yusuke¹³,Yomota Makiko⁴,Furusawa Akiko⁵,Otani Ryohei⁶^ORCID,Saita Chiaki⁷,Yonese Ichiro⁸,Onishi Tomoko⁹,Kobayashi Hiroshi¹⁰,Akiyama Toru¹¹,Shimoyama Tatsu¹,Aruga Tomoyuki³⁷,Yamaguchi Tatsuro³^ORCID

Affiliation:

1. Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

2. Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

3. Department of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

4. Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

5. Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

6. Department of Neurosurgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

7. Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

8. Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

9. Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

10. Department of Orthopedic Surgery, Faculty of Medicine The University of Tokyo Tokyo Japan

11. Department of Orthopedic Surgery, Saitama Medical Center Jichi Medical University Saitama Japan

Funder

Japan Orthopaedics and Traumatology Foundation

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15651

Reference39 articles.

1. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

4. Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

5. Precision oncology and the universal health coverage system in Japan;Ebi H;JCO Precis Oncol,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive genomic profiling from C‐CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1;Clinical Endocrinology;2024-06-09

2. Bayesian parametric estimation based on left-truncated competing risks data under bivariate Clayton copula models;Journal of Applied Statistics;2024-02-22

3. Factors predictive of second‐line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database;Cancer Science;2023-12-19

4. Letter to the editor: left-truncation bias should be considered in prognostic analysis using National Genomic Profiling Database;Japanese Journal of Clinical Oncology;2023-09-30

5. Survival analysis of high-grade salivary gland carcinoma adjusted for length bias due to delay in comprehensive genomic profiling;Japanese Journal of Clinical Oncology;2023-09-30